PFE — Pfizer, Inc. Common Stock
Session close: $28.06. Regular-session share volume: 26,768,917. Change from previous close: -1.44%.
Key developments
Pfizer entered an exclusive licensing agreement with Starna Therapeutics covering three pre-IND in vivo CAR-T programs for autoimmune diseases. Pfizer gains rights outside Greater China to develop, manufacture and commercialize the therapies, drawing on its RNA delivery and immunology expertise to expand its Inflammation & Immunology pipeline.
Company news Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases · Company news Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases
Sector context: market research reports covering medical countermeasures and drug/gene delivery devices list Pfizer among the companies positioned to benefit from pandemic preparedness spending and next-generation delivery platforms. These are industry forecasts rather than company-specific developments.
Company news Global Medical Countermeasures Market 2026: Size, Trends, and Forecast to 2030 | Capitalize on AI, Stockpiling, and Rapid Diagnostics with Pfizer, Moderna, Sanofi, and Emergent · Company news Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate
News sources
Company news Global Medical Countermeasures Market 2026: Size, Trends, and Forecast to 2030 | Capitalize on AI, Stockpiling, and Rapid Diagnostics with Pfizer, Moderna, Sanofi, and Emergent · Company news Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases · Company news Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases · Company news Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate